Scientists discover an essential role for a cell signaling pathway that regulates the early stages of liver regeneration and cancer
Fabregat Hepatology
Discovered a common genetic basis for all dementias
Article Esteller M Translational Psychiatry,
Discovered a common genetic basis for all dementias Read More »
Scientists identify new amino acid transporter in the kidney with potential impact on cystinuria
Research groups led by Dr. Virginia Nunes and Dr. Manuel Palacin, UB professors and researchers from Bellvitge Biomedical Research Institute (IDIBELL) and Institute for Research in Biomedicine Barcelona (IRB Barcelona), respectively, at the same time responsible for the Ciber 730 and U731 units for Rare Diseases (CIBERER), have identified the AGT1/rBAT protein as a new
Cancer stem cell regulation changes during skin carcinoma progression to promote metastasis
Researchers from the group of Aging and Cancer, led by Purificación Muñoz in the Institute of Biomedical Research of Bellvitge (IDIBELL) demonstrated that the cancer stem cell features change during the skin squamous cell carcinoma progression to generate highly aggressive and metastasis prone tumors. These results were recently published in Cancer Research journal. Squamous cell
Genetic engineering to prevent rejection in xenotransplantation
The major limitation involving the transplantation of cells, tissues and organs of animal origin (xenotransplantation, mostly of the pig) in humans is rejection due to the activation of various immune system mechanisms. Overcoming this limitation requires great efforts in xenotransplantation research, such as that led IDIBELL researcher Cristina Costa, who has devoted most of his
Genetic engineering to prevent rejection in xenotransplantation Read More »
Manel Esteller, a world leader in cancer epigenetics and researcher at IDIBELL, receives National Research Prize 2015
The Government of Catalonia and the Catalan Foundation for Research and Innovation (FCRI) have awarded Manel Esteller, researcher at IDIBELL, the National Research Award 2015. Esteller is an ICREA research professor, director of the Epigenetics and Cancer Biology Program of the Institute of Biomedical Research of Bellvitge since 2008, head of the cancer Epigenetics Group of the center and professor of Genetics at the Department of Physiological Sciences II of the Faculty of Medicine of the University of Barcelona.
ERDF Funds subsidize new scientific equipment for IDIBELL
The Spanish Ministry of Economy and Competitiveness (MINECO) has granted a project to Bellvitge Biomedical Research Institute (IDIBELL) for the purchase of scientific equipment intended for laboratories, platforms and other scientific services with high-level technological instrumentation. The project, which is funded by the European Regional Development Fund (ERDF), has a total cost of € 2.290.725,9
ERDF Funds subsidize new scientific equipment for IDIBELL Read More »
UPC students, in collaboration with HUB and IDIBELL present new technologies to improve the treatment of facial paralysis
“Software of image processing as facial neuromuscular therapy in patients with peripheral facial paralysis” is the second project born of the agreement between the Polytechnic University of Catalonia, the University Hospital of Bellvitge (HUB) and IDIBELL to promote biomedical research and technology transfer. On the one hand, the agreement enables UPC students learn about the